by Joel Rothman | Apr 12, 2011 | NutriSupLaw
Editor’s Note: This article is written by Contributing Writer Shafiel A. Karim. As FDA continues to inspect dietary supplement manufacturers under the new CGMP framework, it is clear that many manufacturers share similar deficiencies. Recent FDA warning letters...
by Joel Rothman | Jan 3, 2010 | NutriSupLaw
2009 was an incredible year for the dietary supplement industry. While the rest of American business floundered amidst the depths of a recession, the dietary supplement business thrived. Americans concerned about maintaining their good health stocked up on...
by Joel Rothman | Aug 31, 2009 | NutriSupLaw
This is Part II of the Post that began here in which we discuss the three important suits filed this summer by supplement lawyer Jonathan Emord challenging FDA administrative action on first amendment grounds. The cGMP Challenge – FDA Overreaching? The FDA supplement...
by Joel Rothman | Aug 7, 2009 | NutriSupLaw
The FDA has put supplement companies on notice that violators can expect earlier detection and prosecution. Remarks by commissioner Margaret Hamburg on Aug. 6 strongly suggest that the agency has shifted to a policy of less talk and more action. In a speech to the...
by Joel Rothman | Jul 14, 2009 | NutriSupLaw
Three New Jersey companies that manufacture and sell nutritional supplements and protein powders have just learned what happens when you do not follow health directives from the Food and Drug Administration. Attorneys for the agency are seeking a permanent injunction...
